A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors
Clinical trial NCT05198752 · UNKNOWN
Trial details
- NCT number
- NCT05198752
- Sponsor
- Stemirna Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-18
- Primary completion
- 2023-12-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.